Amazon.com Inc. NASDAQ: AMZN has been quietly but convincingly climbing back into focus. After peaking at an all-time high of $242 in February, shares dropped more than 20%, a move that left many scratching their heads.
Some investors are looking closely at the stocks they own and asking themselves if they could weather an economic slowdown. U.S. President Donald Trump's threats of tariffs against trading partners and recent comments by the Federal Reserve about uncertainty in the economy are sparking fears.
India's state-run product certification agency said it raided the Delhi warehouses of e-commerce giants Amazon and Flipkart this month, seizing items that did not meet quality control standards, as it increased its scrutiny of the two firms.
Amazon's stock price doesn't reflect its improved efficiency, profitability, and focus, creating a disconnect between market perception and reality. Despite a 20% drop from its February high, Amazon's fundamentals, including cash flow and margin expansion, suggest an attractive entry point. AWS investments and cash flow growth highlight Amazon's strategic shift towards reinforcing its infrastructure, positioning it for future enterprise computing dominance.
Amazon has transitioned from a hypergrowth disruptor to a market leader, with its valuation multiples declining as expectations shift toward stable, but still strong, growth. The stock is currently undervalued due to market sentiment and economic uncertainty, creating an attractive buying opportunity at its current price levels. Amazon Web Services (AWS) remains the company's primary growth driver, with its high-margin AI-related offerings positioning it as a foundation for enterprise AI adoption.
Olivier Blanchard says Amazon's (AMZN) reach into agentic A.I. is a "smart move" that will face competition against Alphabet (GOOGL) and Meta Platforms (META).
Dr. Vin Gupta, a high-profile public health expert and clinician, has left Amazon after roughly five years. Gupta most recently served as the chief medical officer of Amazon's online pharmacy business.
Bloomberg's Ryan Vlastelica explains how Amazon shares are stacking up against big tech and retail competitors. He speaks with Caroline Hyde on “Bloomberg Technology”.
Shares of Amazon.com Inc. (NASDAQ: AMZN) slipped alongside the market on Wednesday morning, losing -1.40%, momentarily blunting a rally that has seen the stock gain 5% over the past five trading sessions and reduced its year-to-date loss to -7.89%.
Amazon (AMZN) and Broadcom (AVGO) are the subject of today's Daily Trader with guest host Tom White. Both big tech stocks have fallen from all-time highs, but Tom sees ways to use options and find potential upside in both.
Amazon (AMZN) is testing both a new artificial intelligence (AI) shopping tool that finds new products matching a consumer's interests and a health-focused chatbot, as the company moves forward to deploy the technology on its platforms.
Amazon is the latest tech company to unveil a new generative AI tool intended to personalize your online experience.